Pharsight

Drug patents opposed in 2023

Drug patents opposed in 2023 at the European Patent Office (EPO).

Patent Number Patent Title Company Recent Opposition Date Recent Opposition By Activity Alert
EP3954690B1 Solid forms and formulations of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide ACERTA PHARMA BV 29 Dec, 2023
(Expiration: Jul, 2036)
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP3439647B1 Composition for use in reducing or preventing global developmental delay in children NUTRICIA NV 21 Dec, 2023
(Expiration: Apr, 2036)
SOCIT DES PRODUITS NESTL
EP3416658B1 Human functional corneal endothelial cell and application thereof KYOTO PREFECTURAL PUBLIC UNIV CORP 20 Dec, 2023
(Expiration: Feb, 2037)
VO
EP2658520B1 Leave-in conditioning composition for hair KAO GERMANY GMBH 18 Dec, 2023
(Expiration: Dec, 2031)
HENKEL
EP3290043B1 Enzyme-treated milk product, method for producing same, composition, and product SAISEI PHARMA CO LTD 15 Dec, 2023
(Expiration: May, 2036)
NUTRICIA
EP3645553B1 Tropism-modified recombinant viral particles and uses thereof for the targeted introduction of genetic material into human cells REGENERON PHARMACEUTICALS INC 15 Dec, 2023
(Expiration: Jun, 2038)
STRAWMAN
(and 1 more)
EP3598967B1 Personal cleansing compositions, methods and uses PROCTER AND GAMBLE CO 15 Dec, 2023
(Expiration: Jul, 2038)
UNILEVER UNILEVER
EP3179986B1 Dry powder formulations for inhalation VECTURA INC 14 Dec, 2023
(Expiration: Jul, 2035)
GENERICS UK
EP3727599B8 Composition for dyeing keratin fibers containing a combination of a p-phenylene derivative and 2,7-naphthalenediol and use thereof for reducing a yellow tinge in a hairstyle LABORATOIRE BIOSTHETIQUE KOSMETIK & CO KG GMBH 14 Dec, 2023
(Expiration: Dec, 2037)
HENKEL
EP3512505B1 Vildagliptin pharmaceutical compositions GALENICUM HEALTH SL 13 Dec, 2023
(Expiration: Sep, 2037)
KNPP PARTGMBB
(and 1 more)
EP4070788B1 Pharmaceutical formulations GILEAD SCIENCES INC 11 Dec, 2023
(Expiration: Jun, 2036)
ZENTIVA
EP3042669B1 Antitumor agent and antitumor effect enhancer TAIHO PHARMACEUTICAL CO LTD 07 Dec, 2023
(Expiration: Sep, 2034)
GENERICS UK
(and 1 more)
EP4023755B1 Artificial nucleic acid molecules for improved protein expression CUREVAC SE 06 Dec, 2023
(Expiration: Dec, 2035)
BIONTECH
(and 3 more)
EP3402573B1 Composition containing amino acids INDIVIDUAL 01 Dec, 2023
(Expiration: Jan, 2037)
ARLA FOODS AMBA
(and 1 more)
EP3680249B1 Process for efficient purification of neutral human milk oligosaccharides (hmos) from microbial fermentation CHR HANSEN HMO GMBH 30 Nov, 2023
(Expiration: Dec, 2034)
FRIESLANDCAMPINA NEDERLAND
(and 1 more)
EP3686211B1 Process for efficient purification of neutral human milk oligosaccharides (hmos) from microbial fermentation CHR HANSEN HMO GMBH 30 Nov, 2023
(Expiration: Dec, 2034)
FRIESLANDCAMPINA NEDERLAND
(and 1 more)
EP4066819B1 Small liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 30 Nov, 2023
(Expiration: Aug, 2031)
SANOFI
(and 3 more)
EP4070787B1 Pharmaceutical formulations GILEAD SCIENCES INC 29 Nov, 2023
(Expiration: Jun, 2036)
ZENTIVA
EP3000467B1 Treatment regimen utilizing neratinib for breast cancer WYETH LLC 28 Nov, 2023
(Expiration: Mar, 2030)
ALFRED E TIEFENBACHER
(and 2 more)
EP3880160B1 Dentifrice containing sodium bicarbonate and stannous ions. COLGATE PALMOLIVE CO 27 Nov, 2023
(Expiration: Dec, 2039)
HALEON UK
EP3294283B1 Sacubitril-valsartan dosage regimen for treating heart failure NOVARTIS AG 23 Nov, 2023
(Expiration: May, 2036)
CAMULON
(and 14 more)
EP3302507B1 Diagnostic methods for t cell therapy US DEPARTMENT OF HEALTH AND HUMAN SERVICES 22 Nov, 2023
(Expiration: May, 2036)
BOULT WADE TENNANT
EP3395383B1 Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo REGEN LAB SA 22 Nov, 2023
(Expiration: Aug, 2027)
ESTAR
EP3811943B1 Compound for use in the treatment of ocular disorders AERIE PHARMACEUTICALS INC 22 Nov, 2023
(Expiration: Mar, 2034)
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
(and 2 more)
EP2981272B1 Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease ZS PHARMA INC 22 Nov, 2023
(Expiration: Apr, 2034)
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
EP3880197B1 Methods of treatment for cystic fibrosis VERTEX PHARMACEUTICALS INC 21 Nov, 2023
(Expiration: Nov, 2039)
GENERICS UK
(and 1 more)
EP3393510B1 Zika virus vaccine VALNEVA AUSTRIA GMBH 21 Nov, 2023
(Expiration: Dec, 2036)
MAIWALD
EP3534939B1 Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof BOEHRINGER INGELHEIM VETMEDICA GMBH 21 Nov, 2023
(Expiration: Nov, 2037)
ZOETIS SERVICES
EP3666797B1 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) AMGEN INC 10 Nov, 2023
(Expiration: Aug, 2028)
SANOFI AVENTIS DEUTSCHLAND
(and 1 more)
EP2575744B1 Skin treatment composition UNILEVER GLOBAL IP LTD 27 Oct, 2023
(Expiration: May, 2031)
BEIERSDORF
EP4010082B1 Multispecific anti-tcr delta variable 1 antibodies GAMMADELTA THERAPEUTICS LTD 25 Oct, 2023
(Expiration: Aug, 2041)
MARGARET DIXON
EP3551160B1 Flexible solid cosmetic composition comprising sulfonate anionic surfactants, fatty esters and fatty alcohols, and cosmetic treatment method LOREAL SA 23 Oct, 2023
(Expiration: Nov, 2037)
HENKEL
EP3805248B1 Process for concentration of antibodies and therapeutic products thereof NOVARTIS AG 16 Oct, 2023
(Expiration: Sep, 2025)
CELLTRION
(and 1 more)
EP3318259B1 Stable pharmaceutical composition for oral administration ASTELLAS PHARMA INC 11 Oct, 2023
(Expiration: Jul, 2036)
GENERICS UK
(and 1 more)
EP4011915B8 Methods for treating or preventing asthma by administering an il-4r antagonist SANOFI BIOTECHNOLOGY SAS 11 Oct, 2023
(Expiration: Aug, 2033)
LUIGI
EP2482812B1 Pharmaceutical compositions comprising bi-1356 and metformin BOEHRINGER INGELHEIM INTERNATIONAL GMBH 11 Oct, 2023
(Expiration: Oct, 2030)
LUIGI
(and 2 more)
EP3264923B1 Compositions for use in the prevention or treatment of gastrointestinal infections in infants or young children SOCIETE DES PRODUITS NESTLE SA 10 Oct, 2023
(Expiration: Mar, 2036)
FRIESLANDCAMPINA NEDERLAND
(and 1 more)
EP4043040B1 Small liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 09 Oct, 2023
(Expiration: Aug, 2031)
SANOFI
(and 3 more)
EP3362055B1 Sglt-2 inhibitor for use in the treatment of a metabolic myopathy BOEHRINGER INGELHEIM INTERNATIONAL GMBH 06 Oct, 2023
(Expiration: Oct, 2036)
SANDOZ
(and 1 more)
EP3897726B1 Dietetic butyrate SOCIETE DES PRODUITS NESTLE SA 04 Oct, 2023
(Expiration: Dec, 2039)
AAK PUBL
EP3937662B1 Non-tobacco oral nicotine pouch composition PHILIP MORRIS PRODUCTS SA 04 Oct, 2023
(Expiration: Nov, 2040)
NICOVENTURES TRADING
EP3122426B1 Treating breast cancer using selective estrogen receptor modulators DUKE UNIVERSITY 04 Oct, 2023
(Expiration: Mar, 2035)
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
EP4019041B1 Toxicity management for anti-tumor activity of cars CHILDRENS HOSPITAL OF PHILADELPHIA CHOP 28 Sep, 2023
(Expiration: Jul, 2033)
GEDEON RICHTER PHARMA
(and 2 more)
EP2968201B1 Enhanced drug delivery from adhesives AVERY DENNISON CORP 27 Sep, 2023
(Expiration: Mar, 2034)
BIOCOM SYSTEMS
EP3464277B1 Pegylated carfilzomib compounds AMGEN INC 27 Sep, 2023
(Expiration: May, 2037)
LUIGI
EP3581650B1 Factor ix polypeptide mutant, its uses and a method for its production UNIQURE BIOPHARMA BV 27 Sep, 2023
(Expiration: Sep, 2029)
PFIZER
EP4066855B1 Pegylated liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 27 Sep, 2023
(Expiration: Aug, 2031)
SANOFI
(and 3 more)
EP4008357B1 Small liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 27 Sep, 2023
(Expiration: Aug, 2031)
WEICKMANN & WEICKMANN PARTMBB
(and 3 more)
EP3285776B1 Dosage regimen of vaborbactam and meropenem for treating bacterial infections in subjects with reduced renal function MELINTA THERAPEUTICS INC 21 Sep, 2023
(Expiration: Apr, 2036)
GENERICS UK
EP4066857B1 Pegylated liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 21 Sep, 2023
(Expiration: Aug, 2031)
THOMANN
(and 3 more)
EP3883603B1 Igm protease antigen vaccine for protecting against streptococcus suis INTERVET INTERNATIONAL BV 19 Sep, 2023
(Expiration: Nov, 2039)
CEVA SANTE ANIMALE
EP3318281B1 Highly purified sugars and sugar compositions CORIOLIS PHARMA RESEARCH GMBH 15 Sep, 2023
(Expiration: Nov, 2036)
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
EP3634468B1 Solid compositions for oral administration NOVO NORDISK AS 14 Sep, 2023
(Expiration: Jun, 2038)
GENERICS UK
EP3517539B1 Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes BOEHRINGER INGELHEIM INTERNATIONAL GMBH 14 Sep, 2023
(Expiration: Jul, 2032)
HAMM&WITTKOPP PATENTANWLTE PARTMBB
(and 2 more)
EP3886795B1 Composition for keratin fibers comprising a direct dye LOREAL SA 14 Sep, 2023
(Expiration: Nov, 2039)
HENKEL
EP3138415B1 Metabolic imprinting effects of specifically designed lipid component NUTRICIA NV 14 Sep, 2023
(Expiration: Jun, 2032)
SOCIT DES PRODUITS NESTL
EP3119423B1 Treatment of cancer using chimeric antigen receptor NOVARTIS AG 13 Sep, 2023
(Expiration: Mar, 2035)
MURGITROYD
(and 2 more)
EP3445407B1 Compositions and methods of cellular immunotherapy CRAGE MEDICAL CO LTD 13 Sep, 2023
(Expiration: Apr, 2037)
MURGITROYD
(and 1 more)
EP3471766B1 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens INTERVET INTERNATIONAL BV 12 Sep, 2023
(Expiration: Jun, 2037)
BOEHRINGER INGELHEIM VETMEDICA
EP3694607B1 Compact shampoo composition PROCTER AND GAMBLE CO 12 Sep, 2023
(Expiration: Oct, 2038)
HENKEL
EP3738585B1 Direct compression formulation and process NOVARTIS AG 11 Sep, 2023
(Expiration: Jan, 2025)
HERZOG PATENTANWALTS
EP3532016B1 Method of preparing a product composition comprising a discrete particle and an aqueous base composition PROCTER AND GAMBLE CO 07 Sep, 2023
(Expiration: Apr, 2038)
HENKEL
EP3877395B1 Industrial process for the preparation of high purity estetrol RICHTER GEDEON NYRT 07 Sep, 2023
(Expiration: Sep, 2040)
INDUSTRIALE CHIMICA
EP3752510B1 Macrocycles as modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions thereof, their use in the treatment of cycstic fibrosis, and process for making them VERTEX PHARMACEUTICALS INC 07 Sep, 2023
(Expiration: Feb, 2039)
TEVA PHARMACEUTICAL INDUSTRIES
EP3355919B1 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers JULIUS MAXIMILIANS UNIVERSITAET WUERZBURG 06 Sep, 2023
(Expiration: Sep, 2036)
PFIZER
EP4066856B1 Pegylated liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 06 Sep, 2023
(Expiration: Aug, 2031)
SANOFI
(and 3 more)
EP3578175B1 Rapid dissolution formulation of a calcium receptor-active compound AMGEN INC 30 Aug, 2023
(Expiration: Sep, 2024)
GLENMARK PHARMACEUTICALS EUROPE
(and 6 more)
EP2635537B1 Lithium silicate glasses or glass ceramics, method for production thereof and use thereof FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV 30 Aug, 2023
(Expiration: Jun, 2031)
IVOCLAR VIVADENT
EP2566469B1 Combination therapy BOEHRINGER INGELHEIM INTERNATIONAL GMBH 30 Aug, 2023
(Expiration: May, 2031)
SANDOZ
(and 1 more)
EP3516966B1 A concentrated krill protein hydrolysate fraction RIMFROST TECHNOLOGIES AS 29 Aug, 2023
(Expiration: Sep, 2029)
AKER BIOMARINE ANTARCTIC
EP3067043B1 Pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor NOVARTIS AG 24 Aug, 2023
(Expiration: Nov, 2028)
DR SCHN
(and 5 more)
EP3920970B1 Method for treating checkpoint inhibitors induced adverse events ASSISTANCE PUBLIQUE HOPITAUX DE PARIS APHP 23 Aug, 2023
(Expiration: Feb, 2040)
JG OPPOSITIONS
EP3555064B9 Glp-1 receptor agonists and uses thereof PFIZER INC 23 Aug, 2023
(Expiration: Dec, 2037)
MARGARET DIXON
EP3452050B1 Composition comprising hmos for the treatment of non-infectious diarrhoea GLYCOM AS 23 Aug, 2023
(Expiration: May, 2037)
WEICKMANN & WEICKMANN PARTMBB
EP3459528B1 Preparation of solid dosage forms comprising antibodies by solution/suspension layering TILLOTTS PHARMA AG 22 Aug, 2023
(Expiration: Sep, 2037)
HEIROTH
EP3421034B1 Composite capsule preparation containing tadalafil and tamsulosin and having improved stability and elution rate HANMI PHARMACEUTICAL CO LTD 16 Aug, 2023
(Expiration: Mar, 2037)
GENERICS UK
EP3283058B1 Ribociclib tablet NOVARTIS AG 15 Aug, 2023
(Expiration: Apr, 2036)
GENERICS UK
(and 2 more)
EP3219306B1 Composition comprising citicoline and homotaurine for preventing and treating neuodegenerative diseases and cognitive disorders NEURAXPHARM ITALY SPA 14 Aug, 2023
(Expiration: Mar, 2037)
SIFI
EP3658141B1 Treating pathological conditions by direct and indirect targeting of sirpalpha - cd47 interaction LEIDS UNIVERSITAIR MEDISCH CENTRUM LUMC 11 Aug, 2023
(Expiration: Jul, 2038)
STRAWMAN
EP3302437B8 Stable cannabinoid formulations RADIUS PHARMACEUTICALS INC 09 Aug, 2023
(Expiration: May, 2036)
CARDIOL THERAPEUTICS
EP3256003B1 Lipid extraction processes AKER BIOMARINE ANTARCTIC AS 08 Aug, 2023
(Expiration: Feb, 2036)
RIMFROST
EP3509581B1 Formulations of (r)-2-amino-3-phenylpropyl carbamate JAZZ PHARMACEUTICALS IRELAND LTD 08 Aug, 2023
(Expiration: Sep, 2037)
SANDOZ
EP2838548B1 Hla class ii deficient cells, hla class i deficient cells capable of expressing hla class ii proteins, and uses thereof UNIVERSITY OF WASHINGTON CENTER FOR COMMERCIALIZATION 03 Aug, 2023
(Expiration: Mar, 2033)
JAMES POOLE
EP3458083B1 Polynucleotides encoding interleukin-12 (il12) and uses thereof MODERNATX INC 02 Aug, 2023
(Expiration: May, 2037)
BIONTECH
(and 1 more)
EP3463345B1 Pharmaceutical combinations ARRAY BIOPHARMA INC 01 Aug, 2023
(Expiration: Jun, 2037)
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
(and 1 more)
EP2861226B1 Nutritional product comprising decanoic acid and octanoic acid VITAFLO INTERNATIONAL LTD 01 Aug, 2023
(Expiration: Jun, 2033)
NUTRICIA
(and 1 more)
EP3352768B1 Methods of promoting hepatic regeneration INTERCEPT PHARMACEUTICALS INC 01 Aug, 2023
(Expiration: Sep, 2036)
SANDOZ
(and 2 more)
EP3096781B1 Agents for use in the treatment of retinal inflammation CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS 01 Aug, 2023
(Expiration: Jan, 2035)
STRAWMAN
EP3607069B1 Products and compositions SILENCE THERAPEUTICS GMBH 31 Jul, 2023
(Expiration: Apr, 2038)
AMMELBURG
EP3684381B8 Production of extracellular vesicles in single-cell suspension using chemically-defined cell culture media CODIAK BIOSCIENCES INC 31 Jul, 2023
(Expiration: Sep, 2038)
STRAWMAN
EP3883606B9 Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody JANSSEN BIOTECH INC 27 Jul, 2023
(Expiration: Sep, 2039)
CAMULON
(and 1 more)
EP3723722B1 Thickener and stabilizing system of natural origin for the preparation of cosmetic products ROQUETTE FRERES SA 26 Jul, 2023
(Expiration: Dec, 2038)
BEIERSDORF
(and 1 more)
EP3035958B1 Porcine circovirus type 2 (pcv2) subunit vaccine BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC 26 Jul, 2023
(Expiration: Aug, 2034)
CEVA SANTE ANIMALE
(and 1 more)
EP3578173B1 Dosage form containing oxycodone and naloxone EURO CELTIQUE SA 26 Jul, 2023
(Expiration: Feb, 2026)
ETHYPHARM
(and 4 more)
EP3512545B1 A novel method for stabilization of a biopharmaceutical drug product during processing LEUKOCARE AG 26 Jul, 2023
(Expiration: Sep, 2037)
MAIWALD
EP3554536B1 Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC 26 Jul, 2023
(Expiration: Dec, 2037)
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
EP3345607B1 Methods of altering bone growth by administration of sost or wise antagonist or agonist OSSIFI MAB LLC 26 Jul, 2023
(Expiration: Dec, 2027)
UCB PHARMA UCB PHARMA
(and 3 more)
EP2578231B1 Antitumor t cell response enhancer HOKKAIDO UNIVERSITY NUC 25 Jul, 2023
(Expiration: May, 2031)
GEDEON RICHTER PHARMA
EP3678649B8 Intranasal epinephrine formulations and methods for the treatment of disease AEGIS THERAPEUTICS LLC 24 Jul, 2023
(Expiration: Feb, 2039)
AERA
EP3727300B1 An antimicrobial composition UNILEVER GLOBAL IP LTD 21 Jul, 2023
(Expiration: Dec, 2038)
BEIERSDORF
EP3972552B1 Cosmetic compositions for soft-focus UNILEVER GLOBAL IP LTD 21 Jul, 2023
(Expiration: May, 2040)
LOREAL
EP3530722B1 Detergent composition SHISEIDO CO LTD 19 Jul, 2023
(Expiration: Sep, 2037)
HENKEL
EP2997141B1 Cd19 specific chimeric antigen receptor and uses thereof CELLECTIS SA 12 Jul, 2023
(Expiration: May, 2034)
ACOPAT
EP2959894B1 S1p receptor modulators for treating multiple sclerosis NOVARTIS AG 12 Jul, 2023
(Expiration: Jun, 2027)
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTEL
(and 22 more)
EP3609497B1 Niraparib, abiraterone acetate and prednisone for treating prostate cancer JANSSEN PHARMACEUTICA NV 12 Jul, 2023
(Expiration: Apr, 2038)
GENERICS UK
(and 2 more)
EP3941593B1 An antiperspirant composition comprising reactive salts UNILEVER GLOBAL IP LTD 12 Jul, 2023
(Expiration: Mar, 2040)
LOREAL
EP4005592B1 Virion-like delivery particles for self-replicating rna molecules GLAXOSMITHKLINE BIOLOGICALS SA 12 Jul, 2023
(Expiration: Jul, 2031)
MARGARET DIXON
(and 1 more)
EP3324979B1 Infectious disease vaccines MODERNATX INC 10 Jul, 2023
(Expiration: Jul, 2036)
BIONTECH
EP3157629B1 Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy MEDIMMUNE LTD 04 Jul, 2023
(Expiration: Jun, 2035)
TESARO
EP3302404B1 Microcapsules with high deposition on surfaces FIRMENICH SA 28 Jun, 2023
(Expiration: Jun, 2036)
GIVAUDAN
EP3775125B1 Use of a rhamnolipid biosurfactant to increase the viscosity of a fluid cleaning composition UNILEVER GLOBAL IP LTD 26 Jun, 2023
(Expiration: Apr, 2039)
BEIERSDORF
(and 1 more)
EP3324936B1 Process for the preparation of a bortezomib ester solution STADA ARZNEIMITTEL AG 26 Jun, 2023
(Expiration: Jul, 2036)
STRAWMAN
(and 5 more)
EP3585726B1 Systems and methods for generating nitric oxide THIRD POLE INC 20 Jun, 2023
(Expiration: Feb, 2038)
BEYOND AIR
EP2635282B1 Compositions for treating myelofibrosis IMPACT BIOMEDICINES INC 19 Jun, 2023
(Expiration: Nov, 2031)
ELKINGTON AND FIFE
EP3809884B1 Nicotine pouch product PHILIP MORRIS PRODUCTS SA 16 Jun, 2023
(Expiration: Jun, 2040)
BRITISH AMERICAN TOBACCO INVESTMENTS
EP3310760B8 Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in s1p1 receptor-associated disorders ARENA PHARMACEUTICALS INC 14 Jun, 2023
(Expiration: Jun, 2036)
SCORPIO
(and 1 more)
EP3897543B1 Deposition system for hair UNILEVER GLOBAL IP LTD 13 Jun, 2023
(Expiration: Dec, 2039)
HENKEL
EP3269386B1 Aluminium compounds for use in therapeutics and vaccines VALNEVA AUSTRIA GMBH 13 Jun, 2023
(Expiration: Dec, 2032)
MAIWALD
EP3798214B1 Modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMACEUTICALS INC 12 Jun, 2023
(Expiration: Oct, 2035)
GENERICS UK
EP2981255B1 Therapeutic uses of empagliflozin BOEHRINGER INGELHEIM INTERNATIONAL GMBH 08 Jun, 2023
(Expiration: Apr, 2034)
SANDOZ
(and 9 more)
EP3880802B1 Improved t cell manufacturing process CELGENE CORP 07 Jun, 2023
(Expiration: Nov, 2039)
BOULT WADE TENNANT
EP3694483B1 Sulfate free clear personal cleansing composition comprising low inorganic salt PROCTER AND GAMBLE CO 06 Jun, 2023
(Expiration: Oct, 2038)
LOREAL
(and 7 more)
EP3883393B1 Nutritional composition comprising 2'fucosyllactose and dietary butyrate NUTRICIA NV 06 Jun, 2023
(Expiration: Jun, 2040)
RECKITT BENCKISER HEALTH
(and 3 more)
EP3129044B1 Peptidoglycan hydrolase for use in the treatment of chronic bacterial infections LYSANDO AG 05 Jun, 2023
(Expiration: Apr, 2035)
GLEISS GROE SCHRELL UND PARTNER MBB
(and 1 more)
EP2849754B1 Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis BOEHRINGER INGELHEIM INTERNATIONAL GMBH 05 Jun, 2023
(Expiration: May, 2033)
ZAKLADY FARMACEUTYCZNE POLPHARMA
(and 1 more)
EP3393276B1 High integrity encapsulation product MCCORMICK AND CO INC 02 Jun, 2023
(Expiration: Dec, 2036)
FIRMENICH
EP2954787B1 Liquid enteral nutritional composition with a low monovalent metal ion content NUTRICIA NV 02 Jun, 2023
(Expiration: Jun, 2030)
FRIESLANDCAMPINA NEDERLAND
(and 3 more)
EP3661503B1 Antifungal agents with enhanced activity in acidic ph SCYNEXIS CHEMISTRY AND AUTOMATION INC 02 Jun, 2023
(Expiration: Jul, 2038)
SANDOZ
(and 1 more)
EP2906301B1 Aqueous wax dispersions and hair styling compositions containing them LOREAL SA 01 Jun, 2023
(Expiration: Oct, 2033)
HENKEL
EP3833335B1 Pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate INTAS PHARMACEUTICALS LTD 30 May, 2023
(Expiration: Jul, 2040)
ELKINGTON AND FIFE
EP3478367B1 Fragrance compositions and methods of use thereof TAKASAGO INTERNATIONAL CORP 30 May, 2023
(Expiration: Jun, 2037)
HENKEL
EP3463360B1 Atropine-containing aqueous composition SANTEN PHARMACEUTICAL CO LTD 30 May, 2023
(Expiration: May, 2037)
VYLUMA
(and 1 more)
EP3597216B1 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof ER SQUIBB AND SONS LLC 24 May, 2023
(Expiration: Aug, 2029)
APPLEYARD LEES
(and 4 more)
EP3342782B1 Optimized fc variants XENCOR INC 17 May, 2023
(Expiration: May, 2025)
JAMES POOLE
EP3407880B1 Treatment of rett syndrome with the compound a2-73 ANAVEX LIFE SCIENCES CORP 17 May, 2023
(Expiration: Jan, 2037)
SANDOZ
EP3324937B1 Ready-to-use solution of bortezomib STADA ARZNEIMITTEL AG 15 May, 2023
(Expiration: Jul, 2036)
GRUND
(and 6 more)
EP3386475B1 Composition for cleansing keratin materials with improved rinsing properties LOREAL SA 12 May, 2023
(Expiration: Dec, 2035)
HENKEL
EP3532017B1 Product composition comprising a discrete particle and an aqueous base composition PROCTER AND GAMBLE CO 11 May, 2023
(Expiration: Apr, 2038)
HENKEL
EP3524595B1 High-purity quinoline derivative and method for manufacturing same EISAI R&D MANAGEMENT CO LTD 10 May, 2023
(Expiration: Aug, 2035)
ACCORD HEALTHCARE
(and 8 more)
EP2645997B1 Once daily formulation of lacosamide UCB PHARMA GMBH 10 May, 2023
(Expiration: Dec, 2031)
GENERICS UK
EP3375291B1 A method of inhibiting isomerization of a reducing saccharide upon thermal treatment CHR HANSEN HMO GMBH 10 May, 2023
(Expiration: Mar, 2037)
GLYCOM
(and 1 more)
EP2723303B1 Method for production of a dental restoration FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV 10 May, 2023
(Expiration: Jun, 2032)
IVOCLAR VIVADENT
EP3795137B1 Electrostatically sprayable cosmetic formulation IONIQ SKINCARE GMBH AND CO KG 10 May, 2023
(Expiration: Sep, 2039)
LOREAL
EP3866935B1 Method of reducing perspiration UNILEVER GLOBAL IP LTD 10 May, 2023
(Expiration: Oct, 2039)
THE PROCTER & GAMBLE
EP3448416B1 Semaglutide in cardiovascular conditions NOVO NORDISK AS 09 May, 2023
(Expiration: Apr, 2037)
ADALVO
(and 7 more)
EP2359858B1 Nutritional composition comprising indigestible oligosaccharides NUTRICIA NV 09 May, 2023
(Expiration: Aug, 2025)
FRIESLANDCAMPINA NEDERLAND
(and 1 more)
EP2413971B1 Plant fiber product and method for its manufacture WINNINGTON AB 09 May, 2023
(Expiration: Apr, 2029)
PHILIP MORRIS PRODUCTS
EP3560498B1 Combination comprising an mek inhibitor and a b-raf inhibitor NOVARTIS AG 09 May, 2023
(Expiration: Oct, 2030)
STADA ARZNEIMITTEL
(and 1 more)
EP3716992B1 Use of a vegf antagonist to treat angiogenic eye disorders REGENERON PHARMACEUTICALS INC 05 May, 2023
(Expiration: Nov, 2038)
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
(and 3 more)
EP3749339B1 Marine protein hydrolysate with low fluoride and trimethylamin content AKER BIOMARINE ANTARCTIC AS 03 May, 2023
(Expiration: Jan, 2039)
RIMFROST
EP3209308B1 Activated bifidobacteria and methods of use thereof EVOLVE BIOSYSTEMS INC 03 May, 2023
(Expiration: Oct, 2035)
SOCIT DES PRODUITS NESTL
EP3653221B1 Anti-pvrig antibodies and methods of use COMPUGEN LTD 02 May, 2023
(Expiration: Feb, 2036)
GLAXOSMITHKLINE
(and 1 more)
EP3266306B1 Impregnated textile fabric providing effective delivery of an alcoholic impregnant SCHUELKE AND MAYR GMBH 02 May, 2023
(Expiration: Jun, 2037)
LABORATORIUM DR DEPPE
(and 4 more)
EP3708668B1 Artificial nucleic acid molecules for improved protein expression CUREVAC AG 27 Apr, 2023
(Expiration: Dec, 2035)
BIONTECH
(and 3 more)
EP3097923B1 Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease YEDA RESEARCH AND DEVELOPMENT CO LTD 27 Apr, 2023
(Expiration: Jan, 2028)
JG OPPOSITIONS
EP3206693B1 Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension ALCON INC 27 Apr, 2023
(Expiration: Oct, 2035)
STADA ARZNEIMITTEL
EP2985026B1 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same CLARUS THERAPEUTICS INC 26 Apr, 2023
(Expiration: Apr, 2026)
AERA
EP3845215B1 Oral solutions comprising lisdexamfetamine salts LABOMED PHARMACEUTICAL COMPANY SA 26 Apr, 2023
(Expiration: Dec, 2039)
APPLEYARD LEES
EP3599898B1 Liquid nutritional compositions containing oxidizable fish oil, rosmarinic acid and ferric iron ABBOTT LABORATORIES 26 Apr, 2023
(Expiration: Mar, 2038)
FRESENIUS KABI DEUTSCHLAND
EP2745849B1 Polydeoxyribonucleotides composition and uses thereof ARCHIMEDES SRL 26 Apr, 2023
(Expiration: Dec, 2033)
WITTHOFF JAEKEL STEINECKE PATENTANWLTE PARTG MBB
EP3103476B1 Antibodies against a proliferating inducing ligand (april) ADURO BIOTECH HOLDINGS EUROPE BV 25 Apr, 2023
(Expiration: Feb, 2030)
ZWICKER SCHNAPPAUF & PARTNER PATENTANWLTE PARTG MBB
EP2611467B1 Small liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 20 Apr, 2023
(Expiration: Aug, 2031)
MARGARET DIXON
(and 4 more)
EP2968208B1 Treatment of cataplexy JAZZ PHARMACEUTICALS IRELAND LTD 20 Apr, 2023
(Expiration: Mar, 2034)
SANDOZ
EP3785702B1 Microparticulate varenicline citrate ALFRED E TIEFENBACHER GMBH AND CO KG 19 Apr, 2023
(Expiration: Mar, 2040)
GENERICS UK
EP2477648B1 Synergistic anti-cd47 therapy for hematologic cancers LELAND STANFORD JUNIOR UNIVERSITY 19 Apr, 2023
(Expiration: Sep, 2030)
JG OPPOSITIONS
EP2397142B1 Use of DPP IV inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH 19 Apr, 2023
(Expiration: May, 2027)
ZAKLADY FARMACEUTYCZNE POLPHARMA
(and 4 more)
EP2642876B1 Food product comprising an oligosaccharide mixture and hydrolysed proteins used for reducind food allergies SOCIETE DES PRODUITS NESTLE SA 13 Apr, 2023
(Expiration: Nov, 2031)
NUTRICIA
EP3256099B1 Cosmetic composition comprising linear alpha-olefin sulfonates, anionic and nonionic and/or amphoteric surfactants LOREAL SA 11 Apr, 2023
(Expiration: Dec, 2035)
THE PROCTER & GAMBLE
EP3725810B1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer TRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ GGMBH 06 Apr, 2023
(Expiration: May, 2033)
BAYER BAYER
(and 1 more)
EP3768304B1 Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSERM 06 Apr, 2023
(Expiration: Jul, 2039)
GATESIP
(and 5 more)
EP3615148B1 Compositions with a thickening polymer PROCTER AND GAMBLE CO 06 Apr, 2023
(Expiration: Apr, 2038)
KAO GERMANY
(and 1 more)
EP3773511B1 An oral tablet for induced saliva generation FERTIN PHARMA AS 06 Apr, 2023
(Expiration: May, 2039)
ROQUETTE FRRES
EP3782611B1 Oral formulations of cytidine analogs and methods of use thereof CELGENE CORP 04 Apr, 2023
(Expiration: May, 2029)
TEVA PHARMACEUTICAL INDUSTRIES
(and 4 more)
EP3442489B1 Sunscreen formulations comprising an oleosome suspension and an acidic buffering system BOTANECO INC 31 Mar, 2023
(Expiration: Apr, 2037)
CARGILL
EP3122870B1 Methods and genetic systems for cell engineering GINKGO BIOWORKS INC 29 Mar, 2023
(Expiration: Mar, 2035)
MARKS & CLERK
(and 1 more)
EP3256100B1 Cosmetic composition comprising linear sulfonate olefins and non oxyalkylated anionic surfactants LOREAL SA 29 Mar, 2023
(Expiration: Dec, 2035)
THE PROCTER & GAMBLE
(and 1 more)
EP3773498B1 Liquid pharmaceutical formulation PROJECT PHARMACEUTICS GMBH 22 Mar, 2023
(Expiration: Mar, 2039)
ONCOPEPTIDES
EP3265115B1 Abaloparatide combined with alendronate for reducing non-vertebral bone fractures RADIUS HEALTH INC 21 Mar, 2023
(Expiration: Mar, 2036)
AERA
EP3895712B1 Engineered natural killer cells and uses thereof ONK THERAPEUTICS LTD 21 Mar, 2023
(Expiration: Dec, 2037)
AMMELBURG
EP3638375B1 Hair composition having improved rinsing properties UNILEVER GLOBAL IP LTD 21 Mar, 2023
(Expiration: Jun, 2038)
HENKEL
EP3253865B1 Methods for enhancing efficacy of therapeutic immune cells NATIONAL UNIVERSITY OF SINGAPORE 21 Mar, 2023
(Expiration: Feb, 2036)
PATENT BOUTIQUE
EP3218061B1 Carmustine pharmaceutical composition NAVINTA III INC 17 Mar, 2023
(Expiration: Nov, 2035)
BRAND MURRAY FULLER
EP3601363B1 Alt-803 in combination with anti-cd38 antibody for cancer therapies ALTOR BIOSCIENCE CORP 15 Mar, 2023
(Expiration: Mar, 2038)
CYTUNE PHARMA
EP2883531B1 Bleaching and coloring composition for hair KAO CORP 14 Mar, 2023
(Expiration: Dec, 2033)
LOREAL
EP3542646B1 Seaweed-based powder CARGILL INC 08 Mar, 2023
(Expiration: Mar, 2039)
CP KELCO APS
EP3107548B8 Dry powder formulations for inhalation OTITOPIC INC 08 Mar, 2023
(Expiration: Feb, 2035)
GENERICS UK
EP2872081B1 Systems for corneal cross-linking with pulsed light AVEDRO INC 07 Mar, 2023
(Expiration: Oct, 2032)
DEHNS
EP2903618B1 Rho kinase inhibitors KADMON CORP LLC 28 Feb, 2023
(Expiration: Oct, 2033)
ELKINGTON AND FIFE
(and 1 more)
EP3448435B1 Protein based excipient for active pharmaceutical ingredients ROUSSELOT BV 28 Feb, 2023
(Expiration: Apr, 2037)
GELITA
(and 1 more)
EP3721868B1 Ophthalmic suspension composition BAUSCH AND LOMB INC 28 Feb, 2023
(Expiration: Jan, 2036)
SANDOZ
EP3368572B9 Anti-pd-1 antibodies and compositions SYMPHOGEN AS 24 Feb, 2023
(Expiration: Sep, 2036)
SANOFI
EP3439637B1 Process for mesalazine solid formulations SOFAR SPA 22 Feb, 2023
(Expiration: Apr, 2037)
ELKINGTON AND FIFE
EP3970742B1 Pegylated liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 21 Feb, 2023
(Expiration: Aug, 2031)
THOMANN
(and 4 more)
EP3981427B9 Pegylated liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 21 Feb, 2023
(Expiration: Aug, 2031)
THOMANN
(and 4 more)
EP3505635B1 Widespread gene delivery to motor neurons using peripheral injection of aav vectors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS 17 Feb, 2023
(Expiration: Oct, 2028)
BEZZUBOVA
EP3681483B1 Process for lyophilized pharmaceutical formulation of a therapeutic protein AMGEN INC 17 Feb, 2023
(Expiration: Sep, 2038)
JG OPPOSITIONS
(and 2 more)
EP3733617B1 Low-melting glass ceramic VITA ZAHNFABRIK H RAUTER GMBH AND CO KG 17 Feb, 2023
(Expiration: May, 2039)
RIECK
EP3357911B1 Prolyl hydroxylase inhibitors and methods of use AKEBIA THERAPEUTICS INC 13 Feb, 2023
(Expiration: Jun, 2027)
FIBROGEN
EP3568119B1 Liquid composition comprising hair direct dyes and one or more diols KAO GERMANY GMBH 08 Feb, 2023
(Expiration: Nov, 2037)
HENKEL
(and 1 more)
EP3490575B1 Plant extract highly concentrated in safranal, production method and uses thereof ACTIVINSIDE SAS 06 Feb, 2023
(Expiration: Jul, 2037)
PHARMACTIVE BIOTECH PRODUCTS
EP3059009B1 Process for the storage of refreshing agents SYMRISE AG 03 Feb, 2023
(Expiration: Feb, 2035)
BASF
EP3426226B1 Ophthalmologic composition URSAPHARM ARZNEIMITTEL GMBH 03 Feb, 2023
(Expiration: Mar, 2037)
BITOP
(and 2 more)
EP3261651B1 Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof ICELL GENE THERAPEUTICS LLC 03 Feb, 2023
(Expiration: Feb, 2036)
JAMES POOLE
(and 2 more)
EP3297605B1 Topical pharmaceutical compositions DERMAVANT SCIENCES GMBH 03 Feb, 2023
(Expiration: May, 2036)
SANDOZ
EP3558218B1 Hair lightening composition comprising hydrogen peroxide, a peroxygenated salt, a bicarbonate and at least one polyphosphorus derivative LOREAL SA 02 Feb, 2023
(Expiration: Dec, 2037)
HENKEL
EP3366775B1 Modified rnai agents ALNYLAM PHARMACEUTICALS INC 27 Jan, 2023
(Expiration: Nov, 2032)
AWA SWEDEN
EP3492073B1 Oral mucosa application material and method for producing same RITAPHARMA CO LTD 27 Jan, 2023
(Expiration: Jul, 2037)
CONTIPRO
EP3718565B1 Respiratory virus vaccines MODERNATX INC 27 Jan, 2023
(Expiration: Oct, 2036)
PFIZER
(and 3 more)
EP3169304B1 Sprayable sunscreen composition with oil beads LOREAL SA 26 Jan, 2023
(Expiration: Jul, 2034)
BEIERSDORF
EP3403659B1 Process, tube and device for the preparation of wound healant composition REGEN LAB SA 26 Jan, 2023
(Expiration: Mar, 2031)
ESTAR
EP3042645B1 Dental composites with improved storage stability IVOCLAR VIVADENT AG 26 Jan, 2023
(Expiration: Jan, 2035)
M DEUTSCHLAND DE M INNOVATIVE PROPERTIES
EP3585378B1 Flavanones for use in treating visceral hypersensitivity BIOACTOR BV 26 Jan, 2023
(Expiration: Feb, 2038)
ZBM PATENTS
EP3265122B1 Combination of pembrolizumab and eribulin for treating triple-negative breast cancer EISAI R&D MANAGEMENT CO LTD 23 Jan, 2023
(Expiration: Mar, 2036)
KNIG SZYNKA TILMANN VON RENESSE
(and 3 more)
EP3656860B1 Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof ALNYLAM PHARMACEUTICALS INC 20 Jan, 2023
(Expiration: Jun, 2032)
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
EP3679915B1 Flavivirus vaccines SANOFI PASTEUR BIOLOGICS LLC 20 Jan, 2023
(Expiration: Jan, 2023)
TAKEDA
EP3178490B1 Rsv f protein compositions and methods for making same GLAXOSMITHKLINE BIOLOGICALS SA 19 Jan, 2023
(Expiration: Jul, 2030)
JANSSEN VACCINES & PREVENTION
(and 1 more)
EP3606511B1 Pharmaceutical composition comprising lenvatinib mesylate SYNTHON BV 18 Jan, 2023
(Expiration: Apr, 2038)
TEVA PHARMACEUTICAL INDUSTRIES
EP3166570B1 Two-component self-adhesive dental composition, process of production and use thereof 3M INNOVATIVE PROPERTIES CO 17 Jan, 2023
(Expiration: Jul, 2035)
KULZER
EP3576711B1 Personal care composition PROCTER AND GAMBLE CO 13 Jan, 2023
(Expiration: Feb, 2038)
EDGEWELL PERSONAL CARE BRANDS
EP3199174B1 Uses of neuregulin in preventing, treating or delaying ventricular arrhythmia ZENSUN SHANGHAI SCIENCE AND TECHNOLOGY LTD 13 Jan, 2023
(Expiration: Sep, 2035)
STRAWMAN
EP3694482B1 Sulfate free personal cleansing composition comprising low inorganic salt PROCTER AND GAMBLE CO 12 Jan, 2023
(Expiration: Oct, 2038)
UNILEVER UNILEVER
(and 6 more)
EP3699162B1 Heterodimers of glutamic acid MOLECULAR INSIGHT PHARMACEUTICALS INC 10 Jan, 2023
(Expiration: Nov, 2027)
TELIX INNOVATIONS
EP3238737B1 Means and methods for counteracting muscle disorders LEIDS UNIVERSITAIR MEDISCH CENTRUM LUMC 09 Jan, 2023
(Expiration: Oct, 2028)
BOSCH JEHLE PATENTANWALTSGESELLSCHAFT
(and 1 more)
EP3345602B1 Rapamycin derivative for treating solid tumours NOVARTIS PHARMA AG 06 Jan, 2023
(Expiration: Feb, 2022)
ETHYPHARM
(and 2 more)
EP3773494B1 Nicotine pouch composition and pouch comprising such NCP NEXTGEN AS 06 Jan, 2023
(Expiration: Jun, 2040)
NICOVENTURES TRADING
EP3330279B1 Method for purifying composition comprising antibodies with anionic polymer CHUGAI PHARMACEUTICAL CO LTD 05 Jan, 2023
(Expiration: Jul, 2036)
NEUEFEIND